77 related articles for article (PubMed ID: 9075705)
1. Effects of prostaglandins on human hematopoietic osteoclast precursors.
Roux S; Pichaud F; Quinn J; Lalande A; Morieux C; Jullienne A; de Vernejoul MC
Endocrinology; 1997 Apr; 138(4):1476-82. PubMed ID: 9075705
[TBL] [Abstract][Full Text] [Related]
2. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
3. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
5. Rodent osteoblast-like cells support osteoclastic differentiation of human cord blood monocytes in the presence of M-CSF and 1,25 dihydroxyvitamin D3.
Quinn JM; Fujikawa Y; McGee JO; Athanasou NA
Int J Biochem Cell Biol; 1997 Jan; 29(1):173-9. PubMed ID: 9076952
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.
Takahashi S; Goldring S; Katz M; Hilsenbeck S; Williams R; Roodman GD
J Clin Invest; 1995 Jan; 95(1):167-71. PubMed ID: 7814611
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation.
Haynes DR; Atkins GJ; Loric M; Crotti TN; Geary SM; Findlay DM
Bone; 1999 Sep; 25(3):269-78. PubMed ID: 10495130
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcitonin on the function of human osteoclast-like cells formed from CD14-positive monocytes.
Yamamoto Y; Yamamoto Y; Udagawa N; Okumura S; Mizoguchi T; Take I; Yamauchi H; Yamauchi H; Noguchi T; Takahashi N
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(3):25-31. PubMed ID: 17535751
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 strongly inhibits human osteoclast formation.
Take I; Kobayashi Y; Yamamoto Y; Tsuboi H; Ochi T; Uematsu S; Okafuji N; Kurihara S; Udagawa N; Takahashi N
Endocrinology; 2005 Dec; 146(12):5204-14. PubMed ID: 16150915
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells.
Collins DA; Chambers TJ
J Bone Miner Res; 1992 May; 7(5):555-61. PubMed ID: 1615762
[TBL] [Abstract][Full Text] [Related]
12. CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts.
Ciraci E; Barisani D; Parafioriti A; Formisano G; Arancia G; Bottazzo G; Berardi AC
Exp Hematol; 2007 Jun; 35(6):967-77. PubMed ID: 17533051
[TBL] [Abstract][Full Text] [Related]
13. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
[TBL] [Abstract][Full Text] [Related]
14. Induction of mononuclear precursor cells with osteoclastic phenotypes in a rat bone marrow culture system depleted of stromal cells.
Kukita A; Kukita T; Shin JH; Kohashi O
Biochem Biophys Res Commun; 1993 Nov; 196(3):1383-9. PubMed ID: 8250894
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
Lader CS; Flanagan AM
Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
[TBL] [Abstract][Full Text] [Related]
16. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA.
Rakopoulos M; Ikegame M; Findlay DM; Martin TJ; Moseley JM
Bone; 1995 Nov; 17(5):447-53. PubMed ID: 8579955
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
18. Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling.
Strålberg F; Henning P; Gjertsson I; Kindlund B; Souza PP; Persson E; Abrahamson M; Kasprzykowski F; Grubb A; Lerner UH
FASEB J; 2013 Jul; 27(7):2687-701. PubMed ID: 23572233
[TBL] [Abstract][Full Text] [Related]
19. 12-O-tetradecanoylphorbol-13-acetate inhibits osteoclast-like cell differentiation in rat bone marrow cultures by inducing macrophage polykaryons.
Kukita T; Kukita A; Hata K; Kurisu K
Endocrinology; 1992 Feb; 130(2):577-84. PubMed ID: 1310276
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
Takeshita S; Kaji K; Kudo A
J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
